This is a bronchoscopic view of a smoker male of 50 presente | Figure 1
Rajat_Biswas
Internal Medicine
This is a bronchoscopic view of a smoker male of 50 presented with cough with bloody sputum. What is the tissue diagnosis in this case?
More about this case
Resolved
Trending Cases
A 52-year-old man presented with a 20-minute history of chest pain radiating to the left shoulder and neck, associated with dyspnea and diaphoresis. He had a history of hypertension, long-term smoking, and a sedentary lifestyle. On physical examination, bibasilar crackles were noted on lung auscultation. An electrocardiogram (ECG) was performed in the primary care setting, and the patient was promptly referred to the emergency department.
A 28-year-old woman presented with a 3-day history of intense pruritus over the lower back. She reported no recent travel or exposure to new environments. She cares for a small kennel with approximately eight dogs rescued from the streets. Physical examination revealed multiple small vesicles, some clustered and others scattered, predominantly involving the lumbar region and the left gluteal area.
A 4-month-old male infant presented with skin lesions localized to the chin for the past 3 days. Physical examination revealed multiple small pustules with surrounding inflammatory signs on the chin, along with a few scattered papules on the chest.
A patient in late teens presenting after a collapse, no chest pain, no previous cardiac history, no history of sudden death in family, are there any features in this EKG that would warrant further work-up or is this just a pediatric EKG?
A 75-year-old, nonsmoking white woman was diagnosed with stage IV lung adenocarcinoma. Based on an activating EGFR mutation, she was treated with EGFR tyrosine kinase inhibitors. After 20 months of treatment, dyspnea worsened, with evidence of increased right pleural effusion. A talc pleurodesis was performed and a pleural biopsy revealed the presence of both adenocarcinoma and small-cell lung cancer (SCLC).
Cochrane Review
- 18 trials including 9575 participants with cancer. Most trials included participants with various types of cancer, especially small cell lung cancer, non-small cell lung cancer, and pancreatic cancer.
- The results suggest that the effect of injectable blood thinners on survival is uncertain, but if anything of small size.
- Also, the results suggest that injectable blood thinners reduce the risk of blood clots by about half and possibly increase the risk of major bleeding and minor bleeding by 4 more per 1000 and 17 more per 1000, respectively.
- The effect on quality of life is uncertain. Certainty of evidence was judged to be high for symptomatic VTE and minor bleeding, and moderate for mortality, major bleeding, and quality of life.